{"denoms":[{"counts":[{"groupId":"BG000","value":"35"}],"units":"Participants"}],"groups":[{"description":"Patients received Avelumab 10mg/kg by IV infusion once every 2 weeks. A maximum of 8 cycles, each cycle is 28 days.\n\nAvelumab: anti-PDL1 antibody","id":"BG000","title":"Avelumab"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"11.7","value":"62.1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"35"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"29"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"35"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"denoms":[{"counts":[{"groupId":"BG000","value":"0"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Race and Ethnicity were not collected from any participant.","title":"Race and Ethnicity Not Collected","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"17"}],"title":"Peripheral T-cell lymphoma not otherwise specified"},{"measurements":[{"groupId":"BG000","value":"11"}],"title":"Angioimmunoblastic T-cell lymphoma"},{"measurements":[{"groupId":"BG000","value":"4"}],"title":"Extranodal NK/T-cell lymphoma"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Anaplastic large cell lymphoma"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Transformed mycosis fungoides"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Missing data"}],"denoms":[{"counts":[{"groupId":"BG000","value":"35"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Histology","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"2.0","upperLimit":"3.0","value":"3.0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"35"}],"units":"Participants"}]}],"dispersionType":"INTER_QUARTILE_RANGE","paramType":"MEDIAN","title":"Prior therapies","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"17"}],"title":"0"},{"measurements":[{"groupId":"BG000","value":"13"}],"title":"1"},{"measurements":[{"groupId":"BG000","value":"4"}],"title":"2"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Missing Data"}],"denoms":[{"counts":[{"groupId":"BG000","value":"35"}],"units":"Participants"}]}],"description":"GRADE ECOG PERFORMANCE STATUS\n\n0 Fully active, able to carry on all pre-disease performance without restriction\n\n1. Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work\n2. Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours\n3. Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours\n4. Completely disabled; cannot carry on any selfcare; totally confined to bed or chair\n5. Dead","paramType":"COUNT_OF_PARTICIPANTS","title":"ECOG performance","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"17.3","value":"81.7"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"34"}],"units":"Participants"}]}],"description":"Includes all patients eligible at registration","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"1 patient ineligible post registration","title":"Weight","unitOfMeasure":"kg"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"0.1","value":"1.7"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"34"}],"units":"Participants"}]}],"description":"Includes all patients eligible at registration","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"1 patient was ineligible post registration","title":"Height","unitOfMeasure":"metres"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"5.1","value":"27.0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"34"}],"units":"Participants"}]}],"description":"Includes all patients eligible at registration","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"1 patient was ineligible post registration","title":"BMI","unitOfMeasure":"kg/m2"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"19.7","value":"127.0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"34"}],"units":"Participants"}]}],"description":"Includes all patients eligible at registration","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"1 patient was ineligible post registration","title":"Systolic blood pressure","unitOfMeasure":"mmHg"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.8","value":"74.2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"34"}],"units":"Participants"}]}],"description":"Includes all patients eligible at registration","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"1 patient was ineligible post registration","title":"Diastolic blood pressure","unitOfMeasure":"mmHg"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"21.7","value":"83.7"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"34"}],"units":"Participants"}]}],"description":"Includes all patients eligible at registration","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"1 patient was ineligible post registration","title":"Pulse","unitOfMeasure":"bpm"}],"populationDescription":"Intention to treat population was 35"}